Biosimilar Newsletter Archive

31. 11.27.18 -- How Automation Accelerates Biosimilar Manufacturing With Flexibility And Efficiency
    11/27/2018
    11/27/18 Biosimilar Development Newsletter
32. 11.21.18 -- Where Do Employers Stand With Biosimilars?
    11/21/2018
    11/21/18 Biosimilar Development Newsletter
33. 11.15.18 -- Biosimilars Vs. AbbVie: "Humirapocalypse" Or Illusion?
    11/15/2018
    11/15/18 Biosimilar Development Newsletter
34. 11.14.18 -- Business Strategies That Can Help Speed New Therapeutic Modalities To Market
    11/14/2018
    11/14/18 Biosimilar Development Newsletter
35. 11.08.18 -- Biosimilars, Biobetters, Or Both?: Manufacturing Considerations
    11/8/2018
    11/08/18 Biosimilar Development Newsletter
36. 11.05.18 -- Raw Material Management: Technology Advancements Improving Transparency And Collaboration
    11/5/2018
    11/05/18 Biosimilar Development Newsletter
37. 11.01.18 -- What's Missing From Current Biosimilar Education?
    11/1/2018
    11/01/18 Biosimilar Development Newsletter
38. 10.25.18 -- Humirageddon: Perspectives On The EU Biosimilar Launch
    10/25/2018
    10/25/18 Biosimilar Development Newsletter
39. 10.24.18 -- Smash Bottlenecks In mAb Downstream Processing
    10/24/2018
    10/24/18 Biosimilar Development Newsletter
40. 10.18.18 -- The Humira Biosimilar Tsunami: What To Expect
    10/18/2018
    10/18/18 Biosimilar Development Newsletter